| Autor: |
Friedrich M; Department of Ophthalmology, University of Heidelberg, David J. Apple International Laboratory for Ocular Pathology and International Vision Correction Research Centre (IVCRC), Heidelberg, Germany., Hofmann CA, Chychko L, Son HS, Khoramnia R, Auffarth GU, Augustin VA |
| Abstrakt: |
Competing Interests: Financial disclosures/conflicts of interest: R. Khoramnia reports grants, personal fees, and nonfinancial support from Johnson & Johnson Vision, Alcon Laboratories, Hoya Corp, Kowa Co, Ltd, Oculentis GmbH/Teleon, Physiol S.A., Sifi Medtech Srl, and Rayner Intraocular Lenses Ltd; grants and personal fees from Oculus Optikgeräte GmbH, Carl Zeiss Meditec AG, and Ophtec BV; and grants from Acufocus Inc outside the submitted work. G.U. Auffarth reports lecture fees and research grants from Johnson & Johnson Vision, Alcon Laboratories, Carl Zeiss Meditec AG, Hoya Corp, Kowa Co, Ltd, Oculentis GmbH/Teleon, Physiol S.A., Rayner Intraocular Lenses Ltd, Oculus Optikgeräte GmbH, Ophthec BV, Santen, Sifi Medtech Srl, Acufocus Inc, Novartis, Ursapharm, and Biotech; nonfinancial support from Rheacell, Contamac, Cristalens, Croma, EyeYon, Hanita, and VSY outside the submitted work. V.A. Augustin reports research grants from Kowa Co outside the submitted work. For the remaining authors, none were declared. |
